LEADER 01407nam  2200373Ia 450 
001 9910699236403321
005 20230902162021.0
035   $a(CKB)5470000002401544
035   $a(OCoLC)489496793
035   $a(EXLCZ)995470000002401544
100   $a20091217d1996      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 04$aThe need for long-term rodent carcinogenicity studies of pharmaceuticals$b[electronic resource]
210  1$a[Rockville, MD] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration],$d[1996]
215   $a1 online resource (i, 5 p .)
225 1 $aGuideline for industry ;$vICH S1A
300   $a"March 1996."
410  0$aGuideline for industry ;$vICH-S 1 A.
517 3 $aNeed for long term rodent carcinogenicity studies of pharmaceuticals
606   $aRodents as laboratory animals
606   $aCarcinogenicity testing$xStandards$xInternational cooperation
615  0$aRodents as laboratory animals.
615  0$aCarcinogenicity testing$xStandards$xInternational cooperation.
712 02$aUnited States.$bFood and Drug Administration.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910699236403321
996   $aThe need for long-term rodent carcinogenicity studies of pharmaceuticals$93548154
997   $aUNINA